Chi-Chun Huang

Chi-Chun Huang

Auto-generated profile, based on publicly available information

Chi-Chun Huang

Department of Microbiology and Molecular Genetics, College of Biological Sciences, University of California, Davis, California, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2021 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
HCHung-Lin Chen
Hung-Lin Chen
CLChia-Hui Lo
Chia-Hui Lo
CHChi-Chun Huang
Chi-Chun Huang
MLMeng-Ping Lu
Meng-Ping Lu
PHPo-Yuan Hu
Po-Yuan Hu
FLFu-Tong Liu
Fu-Tong Liu
Psoriasis is a chronic inflammatory skin disease characterized by inflammatory cell infiltration, as well as hyperproliferation of keratinocytes in skin lesions, and is considered a metabolic syndrome. We found that the expression of galectin-7 is reduced in skin lesions of patients with psoriasis. IL-17A and TNF-α, 2 cytokines intimately involved in the development of psoriatic lesions, suppressed galectin-7 expression in human primary keratinocytes (HEKn cells) and the immortalized human keratinocyte cell line HaCaT. A galectin-7 knockdown in these cells elevated the production of IL-6 and IL-8 and enhanced ERK signaling when the cells were stimulated with IL-17A. Galectin-7 attenuated IL-17A–induced production of inflammatory mediators by keratinocytes via the microRNA-146a/ERK pathway. Moreover, galectin-7–deficient mice showed enhanced epidermal hyperplasia and skin inflammation in response to intradermal IL-23 injection. We identified fluvastatin as an inducer of galectin-7 expression by connectivity map analysis, confirmed this effect in keratinocytes, and demonstrated that fluvastatin attenuated IL-6 and IL-8 production induced by IL-17A. Thus, we validate a role of galectin-7 in the pathogenesis of psoriasis, in both epidermal hyperplasia and keratinocyte-mediated inflammatory responses, and formulate a rationale for the use of statins in the treatment of psoriasis.

23 July 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
TLTzu-Han Lo
Tzu-Han Lo
HCHung-Lin Chen
Hung-Lin Chen
CYCheng-I Yao
Cheng-I Yao
IWI-Chun Weng
I-Chun Weng
CLChi-Shan Li
Chi-Shan Li
FLFU-TONG LIU
FU-TONG LIU
Cytosolic lipopolysaccharides (LPSs) bind directly to caspase-4/5/11 through their lipid A moiety, inducing inflammatory caspase oligomerization and activation, which is identified as the noncanonical inflammasome pathway. Galectins, β-galactoside–binding proteins, bind to various gram-negative bacterial LPS, which display β-galactoside–containing polysaccharide chains. Galectins are mainly present intracellularly, but their interactions with cytosolic microbial glycans have not been investigated. We report that in cell-free systems, galectin-3 augments the LPS-induced assembly of caspase-4/11 oligomers, leading to increased caspase-4/11 activation. Its carboxyl-terminal carbohydrate-recognition domain is essential for this effect, and its N-terminal domain, which contributes to the self-association property of the protein, is also critical, suggesting that this promoting effect is dependent on the functional multivalency of galectin-3. Moreover, galectin-3 enhances intracellular LPS-induced caspase-4/11 oligomerization and activation, as well as gasdermin D cleavage in human embryonic kidney (HEK) 293T cells, and it additionally promotes interleukin-1β production and pyroptotic death in macrophages. Galectin-3 also promotes caspase-11 activation and gasdermin D cleavage in macrophages treated with outer membrane vesicles, which are known to be taken up by cells and release LPSs into the cytosol. Coimmunoprecipitation confirmed that galectin-3 associates with caspase-11 after intracellular delivery of LPSs. Immunofluorescence staining revealed colocalization of LPSs, galectin-3, and caspase-11 independent of host N-glycans. Thus, we conclude that galectin-3 amplifies caspase-4/11 oligomerization and activation through LPS glycan binding, resulting in more intense pyroptosis—a critical mechanism of host resistance against bacterial infection that may provide opportunities for new therapeutic interventions. Significance Cytosolic lipopolysaccharides (LPSs) induce oligomerization of caspase-4/5/11, resulting in pyroptosis, but the involvement of any other host resistance factors in this process is unknown. Galectins bind to components of pathogenic microorganisms, particularly LPSs, in a glycan-dependent manner. However, these proteins are mainly present intracellularly, and little is known regarding their functions associated with binding to components of microorganisms, including LPSs, in the cytosol. Here, we report that galectin-3 recognizes cytosolic LPSs from various bacteria and amplifies LPS-induced caspase-4/11 oligomerization and activation, causing more intense pyroptosis in a carbohydrate-dependent manner. This study defines a unique molecular mechanism based on the carbohydrate-binding and self-association properties of galectin-3, through which this glycan-binding protein enhances cytosolic LPS-induced noncanonical inflammasome activation in macrophages.

1 March 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
YLYuan-Hsin Lo
Yuan-Hsin Lo
CLChi-Shan Li
Chi-Shan Li
HCHung-Lin Chen
Hung-Lin Chen
CCCho-Ying Chiang
Cho-Ying Chiang
CHChi-Chun Huang
Chi-Chun Huang
FLFU-TONG LIU
FU-TONG LIU

22 August 2022 in Journal of Biological Chemistry
Verified
Journal Article
Open access
BGBenjamin Groth
Benjamin Groth
CHChi-Chun Huang
Chi-Chun Huang
SLSu-Ju Lin
Su-Ju Lin
NAD+ is a cellular redox cofactor involved in many essential processes. The regulation of NAD+ metabolism and the signaling networks reciprocally interacting with NAD+-producing metabolic pathways are not yet fully understood. The NAD+-dependent histone deacetylase (HDAC) Hst1 has been shown to inhibit de novo NAD+ synthesis by repressing biosynthesis of nicotinic acid (BNA) gene expression. Here, we alternatively identify HDAC Rpd3 as a positive regulator of de novo NAD+ metabolism in the budding yeast Saccharomyces cerevisiae. We reveal that deletion of RPD3 causes marked decreases in the production of de novo pathway metabolites, in direct contrast to deletion of HST1. We determined the BNA expression profiles of rpd3Δ and hst1Δ cells to be similarly opposed, suggesting the two HDACs may regulate the BNA genes in an antagonistic fashion. Our chromatin immunoprecipitation analysis revealed that Rpd3 and Hst1 mutually influence each other’s binding distribution at the BNA2 promoter. We demonstrate Hst1 to be the main deacetylase active at the BNA2 promoter, with hst1Δ cells displaying increased acetylation of the N-terminal tail lysine residues of histone H4, H4K5, and H4K12. Conversely, we show that deletion of RPD3 reduces the acetylation of these residues in an Hst1-dependent manner. This suggests that Rpd3 may function to oppose spreading of Hst1-dependent heterochromatin and represents a unique form of antagonism between HDACs in regulating gene expression. Moreover, we found that Rpd3 and Hst1 also coregulate additional targets involved in other branches of NAD+ metabolism. These findings help elucidate the complex interconnections involved in effecting the regulation of NAD+ metabolism.